Merck Laying Off 150 Workers at North Carolina Site

Merck will cut 150 jobs at its North Carolina site in May after Gardasil sales fell. The move follows changes to vaccine schedules and lower demand in China.

Xurve View
洞察:

Merck & Co., Inc. is set to reduce its workforce by approximately 150 employees at a manufacturing facility in North Carolina. The site is responsible for producing Gardasil, the company's vaccine against human papillomavirus (HPV). This decision follows a significant downturn in global sales for the product, which was previously considered a primary growth engine for the pharmaceutical giant.

The Merck logo displayed at the entrance of the company's campus in Rahway, New Jersey. REUTERS/Brendan McDermid/File Photo
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。